(Q40019405)

English

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

scientific article published on March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 September 2017

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus (English)

1 reference

Europe PubMed Central

16 September 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Norman M Kneteman

1

1 reference

Europe PubMed Central

16 September 2017

Anita Y M Howe

2

1 reference

Europe PubMed Central

16 September 2017

Tiejun Gao

3

1 reference

Europe PubMed Central

16 September 2017

Jamie Lewis

4

1 reference

Europe PubMed Central

16 September 2017

Dan Pevear

5

1 reference

Europe PubMed Central

16 September 2017

Gary Lund

6

1 reference

Europe PubMed Central

16 September 2017

Donna Douglas

7

1 reference

Europe PubMed Central

16 September 2017

David F Mercer

8

1 reference

Europe PubMed Central

16 September 2017

D Lorne J Tyrrell

9

1 reference

Europe PubMed Central

16 September 2017

Frederick Immermann

10

1 reference

Europe PubMed Central

16 September 2017

Inder Chaudhary

11

1 reference

Europe PubMed Central

16 September 2017

John Speth

12

1 reference

Europe PubMed Central

16 September 2017

Stephen A Villano

13

1 reference

Europe PubMed Central

16 September 2017

John O'Connell

14

1 reference

Europe PubMed Central

16 September 2017

Marc Collett

15

1 reference

Europe PubMed Central

16 September 2017

language of work or name

0 references

publication date

1 March 2009

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

49

1 reference

Europe PubMed Central

16 September 2017

745-752

1 reference

Europe PubMed Central

16 September 2017

3

1 reference

Europe PubMed Central

16 September 2017

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Hepatitis C treatment update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Hepatitis C virus replication in mice with chimeric human livers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Comparative features of hepatitis C virus infection in humans and chimpanzees

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Robust hepatitis C virus infection in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Complete replication of hepatitis C virus in cell culture

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Hepatitis C virus replication during acute infection in the chimpanzee

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Hepatitis C virus viremia in SCID-->BNX mouse chimera

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Transmission of hepatitis C virus infection to tree shrews

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Complete reconstitution of mouse liver with xenogeneic hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

21 January 2018

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

7 January 2021

based on heuristic

inferred from DOI database lookup

Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

7 January 2021

based on heuristic

inferred from DOI database lookup

Replacement of diseased mouse liver by hepatic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten years of highly active antiretroviral therapy for HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22717

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22717

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40019405&oldid=1882687543"